Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial

DOI: 10.1038/s41541-018-0083-3

Full-Text   Cite this paper   Add to My Lib

Abstract:

Demographics and baseline characteristics in 10, 25 and 50？μg PvDBPII vaccine and 20？μg Hepatitis B vaccine groups–ITT Populatio

Full-Text